Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
NCT07176689
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Desmoid Tumor
Aggressive Fibromatosis
Interventions
DRUG:
Nirogacestat
Sponsor
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany